Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Ocean Equities
Sydney, New South Wales, Australia
- Ownership
- Private
- Employees
- ~27
- Development stage
- Other
01
Overview
Blue Ocean Equities is an Australian financial services firm providing securities dealing, equity research, and corporate advisory services. The firm is focused on institutional, wholesale, and high-net-worth investors as well as corporate clients, with activity in Australian equities and capital markets. It appears to serve multiple sectors, including life sciences, resources, and industrial companies, but it is not itself a biotech, pharma, or healthcare operating company. For biotech analysts, Blue Ocean Equities is best understood as a sector-facing capital markets and brokerage adviser rather than a therapeutic developer.
- Industry
- Investors
Beyond the preview
Go deeper on Blue Ocean Equities.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blue Ocean Equities.